Global Hematology Analyzers and Reagents Market, By Product and Services (Hematology Products and Services, Hemostasis Products and Services, Immunohematology Products and Services, Plasma Protein Analyzer, Haemoglobin Analyzers, Erythrocyte Sedimentation Rate Analyzer, Coagulation Analyzer, Flow Cytometers, Differential Counters), Price Range (High-End, Mid-Range, Low-End), Application (Anemia, Blood Cancer, Hemorrhagic Conditions, Infection-Related Conditions, Immune System Related Conditions, Others), End User (Hospital Laboratories, Blood Banks, Commercial Service Providers, Government Reference Laboratories, Research and Academic Institute, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029
Market Analysis and Insights Hematology Analyzers and Reagents Market
Data Bridge Market Research analyses that the hematology analyzers and reagents market to account USD 6,958.94 million by 2029 by growing at a CAGR of 7.00% in the forecast period of 2022-2029.
Hematology analyzers and reagents are healthcare products and consumables designed to spot and count individual blood cells in an exceedingly extremely economical and high-speed manner. These instruments have replaced the standard strategies of numeration blood cells on an individual basis beneath a magnifier that was dispensed antecedently by the research laboratory technicians.
Rising volume of blood donation in combination with high prevalence of blood disorders is the major factor accelerating the growth of the hematology analyzers and reagents market in the forecast period of 2022-2029. Furthermore, innovations and advancements in technology such as the integration of hematology analyzers with flow cytometry instrumentations is also expected to drive the growth of the hematology analyzers and reagents market in the forecast period of 2022-2029. However, lack of preference resulting in slow adoption rate of this instrumentation in the developing regions of the world restrains the growth of the hematology analyzers and reagents market in the forecast period of 2022-2029. Also, increasing concerns amongst consumers regarding the safety and effectiveness of these devices will challenge market growth in the above mentioned forecast period.
In addition, increasing focus of market players on the development of high throughput analysing instruments along with the focus on developing highly sensitive point-of-care test instruments and products will create ample opportunities for the hematology analyzers and reagents market in the above mentioned forecast period.
This hematology analyzers and reagents market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on hematology analyzers and reagents market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Hematology Analyzers and Reagents Market Scope and Market Size
The hematology analyzers and reagents market is segmented on the basis of product and services, price range, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product and services, the hematology analyzers and reagents market has been segmented into hematology products and services, hemostasis products and services, immunohematology products and services, plasma protein analyzer, haemoglobin analyzers, erythrocyte sedimentation rate analyzer, coagulation analyzer, flow cytometers and differential counters. Hematology products and services have been sub-segmented into instruments, reagents and consumables and services. Instruments have been sub-segmented into 5-part and 6-part fully automated hematology analyzers, 3-part fully automated hematology analyzers, semi-automated hematology analyzers, point-of-care testing hematology analyzers and highly complex clinical laboratory analyzer. Reagents and consumables have been sub-segmented into hematology reagents, slide strainers/makers, controls and calibrators and consumables. Hemostasis products and services have been sub-segmented into instruments, reagents and consumables and services. Immunohematology products and services have been sub-segmented into instruments, reagents and consumables and services.
- Based on price range, the hematology analyzers and reagnets market has been segmented into high-end, mid-range and low-end.
- Hematology analyzers and reagents market has been segmented on the basis of application into anemia, blood cancer, hemorrhagic conditions, infection-related conditions, immune-system related conditions and others.
- Hematology analyzers and reagents market has also been segmented into hospital laboratories, blood banks, commercial service providers, government reference laboratories, research and academic institute and others based on end user.
Hematology Analyzers and Reagents Market Country Level Analysis
The hematology analyzers and reagents market is analysed and market size insights and trends are provided by country, product and services, price range, application and end user as referenced above.
The countries covered in the hematology analyzers and reagents market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the hematology analyzers and reagents market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the high presence of individuals suffering from various blood-related disorders along with the high growth witnessed in blood transfusions carried out in this region. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period due to the governments of these regions imposing favourable regulations and compliances for the consumption of advanced medical instrumentations.
The country section of the hematology analyzers and reagents market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The hematology analyzers and reagents market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for hematology analyzers and reagents market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the hematology analyzers and reagents market. The data is available for historic period 2010 to 2020.
Competitive Landscape and Hematology Analyzers and Reagents Market Share Analysis
The hematology analyzers and reagents market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to hematology analyzers and reagents market.
Some of the major players operating in the hematology analyzers and reagents market are Sysmex Corporation, Danaher, NIHON KOHDEN CORPORATION, Siemens Healthcare GmbH, Abbott, Boule Diagnostics, Bio-Rad Laboratories, Inc., Biosystems S.A., Diatron, EKF Diagnostics, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Erba Mannheim, Ortho Clinical Diagnostics, Abaxis, Heska Corporation, F. Hoffmann-La Roche Ltd, HORIBA, Ltd., Neomedica and Abbott among others.
SKU-